Lifeloc reports Q3 revenue up 21% YoY; net income of $0.21/share vs loss year ago

Lifeloc Technologies, Inc

2021-Q3 EPS reported $0.33 revenue$5,426,667

Q3 2021 net revenue $1.887M (+21% YoY); net income $523k ($0.21 diluted EPS) vs loss of $0.09/share in Q3 2020.
Nine-month 2021 revenue $5.427M; net income $816k ($0.33 diluted EPS) vs loss $0.30/share prior year.
Results include $471k PPP loan forgiveness in Q3; total $936k for nine months.
Refinanced building mortgage from 4.00% to 2.95% fixed rate through Sept 2031.
New L-series devices (LX9, LT7) driving demand; R.A.D.A.R. 200 field testing; SpinDx breathalyzer expected revenue by late 2022.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.